COHANCE — Cohance Lifesciences Share News
0.000.00%
Last trade - 00:00- IN₹177.54bn
- IN₹179.50bn
- IN₹22.69bn
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss
Brief: Cohance Lifesciences Says USFDA Conducted Inspection At Hyderabad Manufacturing Facility
India's Cohance slips as quarterly profit slumps; Jefferies cuts rating, PT
Brief: Cohance Lifesciences March-Quarter Consol Net Profit 195.5 Million Rupees
Brief: Cohance Lifesciences Says Vivek Sharma Resigns As Executive Chairman
India's Cohance sees biggest pct gain in 6 years as former Cipla chief appointed CEO
Brief: Cohance Lifesciences Says Umang Vohra Designated As Chairman And CEO
Brief: Jasti Family Trust Sells 7.7 Million Shares Of Cohance Lifesciences In Bulk Deal; Jasub Property Buys Stake
Brief: Cohance Lifesciences Says USFDA Issues Warning Letter To Cohance Facility
India's Cohance falls after JP Morgan downgrade, eyes longest losing run on record
India's Cohance Lifesciences hits near 1-1/2-year low on quarterly profit slump
Brief: Cohance Lifesciences Posts Sept-Qtr Consol Net Profit 740.8 Million Rupees
India's Cohance falls as MD steps down
India's Cohance falls on discounted block deal
Brief: Cohance Lifesciences Says USFDA Completes CGMP Audit At Andhra Pradesh Facility
IIFL Capital starts coverage on India's Cohance with 'buy'